Skip to main content

Advertisement

ADVERTISEMENT

Volume 22 - Issue 2 - February 2022

Feature

Case Study
02/01/2022

Ziad F. Issa, MD, MMM, 

Prairie Heart Institute, 

Springfield, Illinois

Ziad F. Issa, MD, MMM,  Prairie Hear...
Dr. Issa presents 3 patients who underwent transvenous lead extraction for noninfectious indications utilizing an intraprocedural risk stratification approach to guide decision-making regarding lead abandonment versus extraction.
Dr. Issa presents 3 patients who underwent transvenous lead extraction for noninfectious indications utilizing an intraprocedural risk stratification approach to guide decision-making regarding lead abandonment versus extraction.
Dr. Issa presents 3 patients who...
02/01/2022
EP Lab Digest
Cover Story
02/01/2022

Vidhushei Yogeswaran, MD1*; Jacob J. Mayfield, MD1*; Patrick M. Boyle, PhD2-4; Arun R. Sridhar, MBBS, MPH1

*VY and JJM are equal contributors to this publication. 1Department of Medicine, Division of Cardiology, University of Washington Medical Center, Seattle, Washington; 2Department of Bioengineering, University of Washington, Seattle, Washington; 3Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington; 4Center for Cardiovascular Biology, University of Washington, Seattle, Washington

Vidhushei Yogeswaran, MD1*; Jacob J. ...
The authors describe how artificial intelligence, and specifically machine learning, have shown great potential to improve many facets of cardiovascular medicine and electrophysiology.
The authors describe how artificial intelligence, and specifically machine learning, have shown great potential to improve many facets of cardiovascular medicine and electrophysiology.
The authors describe how...
02/01/2022
EP Lab Digest
Case Study
02/01/2022

Jake Goldstein, BS; Alexander Turin, MD; Sukit Ringwala, MD; Peter A. Santucci, MD; Smit Vasaiwala, MD

Loyola University Medical Center, Maywood, Illinois

Jake Goldstein, BS; Alexander Turin, ...
Jake Goldstein, BS, and colleagues present a systematic approach to catheter ablation in a patient presenting with ventricular tachycardia in the setting of ischemic heart disease.
Jake Goldstein, BS, and colleagues present a systematic approach to catheter ablation in a patient presenting with ventricular tachycardia in the setting of ischemic heart disease.
Jake Goldstein, BS, and...
02/01/2022
EP Lab Digest
Case Study
02/01/2022

Jordan S. Leyton-Mange, MD1,2; Edmund E. Presby, RCIS, RCES1; Lauren L. Russell, RN1; Christina M. Conley, RCIS, RCES1

1Department of Cardiology, Maine Medical Center, Portland, Maine; 2Maine Medical Partners - MaineHealth Cardiology, Scarborough, Maine

Jordan S. Leyton-Mange, MD1,2; Edmund...
Dr. Leyton-Mange and colleagues describe a case of premature ventricular contractions arising from the cardiac crux.
Dr. Leyton-Mange and colleagues describe a case of premature ventricular contractions arising from the cardiac crux.
Dr. Leyton-Mange and colleagues...
02/01/2022
EP Lab Digest
Spotlight Interview
02/01/2022

Alexandru Costea, MD

Director of the Electrophysiology Center at UC Heart, Lung, and Vascular Institute, Director of EP Lab, University of Cincinnati Medical Center, Cincinnati, Ohio

Alexandru Costea, MD Director of the...
The facility at the University of Cincinnati Medical Center, located in Cincinnati, Ohio, includes 2 EP labs and 1 hybrid room.
The facility at the University of Cincinnati Medical Center, located in Cincinnati, Ohio, includes 2 EP labs and 1 hybrid room.
The facility at the University...
02/01/2022
EP Lab Digest
EP Perspectives
01/31/2022

Kateryna Metersky, PhD, RN

Kateryna Metersky, PhD, RN
Dr. Metersky, who received the diagnosis of non-sustained ventricular tachycardia in 2019, composes poetry to explain difficult and theoretical concepts to nursing and interprofessional students, as well as patients in her care.
Dr. Metersky, who received the diagnosis of non-sustained ventricular tachycardia in 2019, composes poetry to explain difficult and theoretical concepts to nursing and interprofessional students, as well as patients in her care.
Dr. Metersky, who received the...
01/31/2022
EP Lab Digest

Column

Letter from the Editor
02/01/2022

Bradley P. Knight, MD, FACC, FHRS, Editor-in-Chief

Bradley P. Knight, MD, FACC, FHRS, Ed...
Although one could argue that the differences between the two DOACs are trivially small, the findings from a recent study do seem to make a very strong case that apixaban is actually “better” than rivaroxaban.
Although one could argue that the differences between the two DOACs are trivially small, the findings from a recent study do seem to make a very strong case that apixaban is actually “better” than rivaroxaban.
Although one could argue that...
02/01/2022
EP Lab Digest

Advertisement

Advertisement

Advertisement